Andrea Visentin

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 67

Top Venues

Cancers

Current oncology (Toronto, Ont.)

Hematological oncology

American journal of hematology

University of Padua

University of Padua (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Padua May 04 2020

Italy

Assistant professor :: Department of Medicine

University of Padua Sep 01 2017 - Mar 01 2020

Italy

Post doc fellowship :: Department of Medicine

Education History

University of Padua Oct 01 2016

Italy

PHD

Publications

Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta, Ivan Zatta, Andrea Serafin, Stefano Pravato, Elisa Pagnin, Laura Bonaldi, Federica Frezzato, Monica Facco, Francesco A Piazza, Livio Trentin, Andrea Visentin
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course. Cancers 16 (6) (2024)
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, Cristina Ulivieri, Nagaja Capitani, Carmela Tangredi, Francesca Finetti, Giuseppe Marotta, Federica Frezzato, Andrea Visentin, Sara Ciofini, Alessandro Gozzetti, Monica Bocchia, Diego Calzada-Fraile, Noa B Martin Cofreces, Livio Trentin, Laura Patrussi, Cosima Tatiana Baldari
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. Cell death & disease 15 (2) (2024)
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi, Ivan Zatta, Federica Frezzato, Laura Bonaldi, Annalisa Martines, Stefano Pravato, Francesco Piazza, Livio Trentin, Andrea Visentin
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens. British journal of haematology 205 (1) (2024)
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, Cristina Ulivieri, Nagaja Capitani, Carmela Tangredi, Francesca Finetti, Giuseppe Marotta, Federica Frezzato, Andrea Visentin, Sara Ciofini, Alessandro Gozzetti, Monica Bocchia, Diego Calzada-Fraile, Noa B Martin Cofreces, Livio Trentin, Laura Patrussi, Cosima Tatiana Baldari
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. Cell death & disease 15 (2) (2024)
Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta, Ivan Zatta, Andrea Serafin, Stefano Pravato, Elisa Pagnin, Laura Bonaldi, Federica Frezzato, Monica Facco, Francesco A Piazza, Livio Trentin, Andrea Visentin
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course. Cancers 16 (6) (2024)
Nicolò Danesin, Greta Scapinello, Dorella Del Prete, Elena Naso, Tamara Berno, Andrea Visentin, Laura Bonaldi, Annalisa Martines, Roberta Bertorelle, Fabrizio Vianello, Carmela Gurrieri, Renato Zambello, Chiara Castellani, Marny Fedrigo, Stefania Rizzo, Annalisa Angelini, Livio Trentin, Francesco A Piazza
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario. Cancer reports (Hoboken, N.J.) 7 (4) (2024)
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, Cristina Ulivieri, Nagaja Capitani, Carmela Tangredi, Francesca Finetti, Giuseppe Marotta, Federica Frezzato, Andrea Visentin, Sara Ciofini, Alessandro Gozzetti, Monica Bocchia, Diego Calzada-Fraile, Noa B Martin Cofreces, Livio Trentin, Laura Patrussi, Cosima Tatiana Baldari
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. Cell death & disease 15 (2) (2024)
Andrea Visentin, Sara Frazzetto, Livio Trentin, Annalisa Chiarenza
Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review. Cancers 16 (7) (2024)
Andrea Visentin, Sara Frazzetto, Livio Trentin, Annalisa Chiarenza
Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review. Cancers 16 (7) (2024)
Nicolò Danesin, Greta Scapinello, Dorella Del Prete, Elena Naso, Tamara Berno, Andrea Visentin, Laura Bonaldi, Annalisa Martines, Roberta Bertorelle, Fabrizio Vianello, Carmela Gurrieri, Renato Zambello, Chiara Castellani, Marny Fedrigo, Stefania Rizzo, Annalisa Angelini, Livio Trentin, Francesco A Piazza
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario. Cancer reports (Hoboken, N.J.) 7 (4) (2024)
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi, Ivan Zatta, Federica Frezzato, Laura Bonaldi, Annalisa Martines, Stefano Pravato, Francesco Piazza, Livio Trentin, Andrea Visentin
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens. British journal of haematology (2024)
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, Cristina Ulivieri, Nagaja Capitani, Carmela Tangredi, Francesca Finetti, Giuseppe Marotta, Federica Frezzato, Andrea Visentin, Sara Ciofini, Alessandro Gozzetti, Monica Bocchia, Diego Calzada-Fraile, Noa B Martin Cofreces, Livio Trentin, Laura Patrussi, Cosima Tatiana Baldari
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. Cell death & disease 15 (2) (2024)
Nicolò Danesin, Greta Scapinello, Dorella Del Prete, Elena Naso, Tamara Berno, Andrea Visentin, Laura Bonaldi, Annalisa Martines, Roberta Bertorelle, Fabrizio Vianello, Carmela Gurrieri, Renato Zambello, Chiara Castellani, Marny Fedrigo, Stefania Rizzo, Annalisa Angelini, Livio Trentin, Francesco A Piazza
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario. Cancer reports (Hoboken, N.J.) 7 (4) (2024)
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, Cristina Ulivieri, Nagaja Capitani, Carmela Tangredi, Francesca Finetti, Giuseppe Marotta, Federica Frezzato, Andrea Visentin, Sara Ciofini, Alessandro Gozzetti, Monica Bocchia, Diego Calzada-Fraile, Noa B Martin Cofreces, Livio Trentin, Laura Patrussi, Cosima Tatiana Baldari
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. Cell death & disease 15 (2) (2024)
Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Andrea Visentin, Sara Frazzetto, Livio Trentin, Annalisa Chiarenza
Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review. Cancers 16 (7) (2024)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Andrea Visentin, Francesca Romana Mauro, Lydia Scarfò, Massimo Gentile, Lucia Farina, Gianluigi Reda, Isacco Ferrarini, Giulia Proietti, Enrico Derenzini, Francesca Cibien, Candida Vitale, Alessandro Sanna, Daniela Pietrasanta, Monia Marchetti, Roberta Murru, Gian Matteo Rigolin, Paolo Sportoletti, Valentina Trimarco, Chiara Adele Cavarretta, Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Ivan Zatta, Luca Laurenti, Stefano Molica, Marta Coscia, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study. American journal of hematology (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, Anargyros Kapetanakis, Christos Demosthenous, Georgios Karakatsoulis, null null
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. American journal of hematology (2023)
Giuseppe Maggioni, Marny Fedrigo, Andrea Visentin, Elisa Carturan, Valeria Ruocco, Livio Trentin, Mauro Alaibac, Annalisa Angelini
Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature. Current oncology (Toronto, Ont.) 30 (9) (2023)
Filippo Severin, Nayla Mouawad, Edoardo Ruggeri, Andrea Visentin, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Stefano Pravato, Francesco Angotzi, Monica Facco, Livio Trentin, Federica Frezzato
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness. British journal of haematology (2023)
Francesca Romana Mauro, Diana Giannarelli, Clementina M Galluzzo, Andrea Visentin, Anna Maria Frustaci, Paolo Sportoletti, Candida Vitale, Gianluigi Reda, Massimo Gentile, Luciano Levato, Roberta Murru, Daniele Armiento, Maria C Molinari, Giulia Proietti, Sara Pepe, Filomena De Falco, Veronica Mattiello, Luca Barabino, Roberta Amici, Marta Coscia, Alessandra Tedeschi, Corrado Girmenia, Livio Trentin, Silvia Baroncelli
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. Cancers 15 (11) (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Paola Alberti, Alessandro Salvalaggio, Haralabos P Kalofonos, Jordi Bruna, Andrea Visentin, Guido Cavaletti, Chiara Briani
Neurological Complications of Conventional and Novel Anticancer Treatments. Cancers 14 (24) (2022)
Francesco Angotzi, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos, Livio Trentin
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. Current oncology (Toronto, Ont.) 29 (3) (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Mario Angelo Pagano, Federica Frezzato, Andrea Visentin, Livio Trentin, Anna Maria Brunati
Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia. Cancers 14 (19) (2022)
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, Livio Pagano, Anna Guidetti, Pellegrino Musto, Riccardo Bruna, Monica Bocchia, Andrea Visentin, Mauro Turrini, Alessandra Tucci, Sofia Pilerci, Luana Fianchi, Marco Salvini, Sara Galimberti, Elisa Coviello, Carmine Selleri, Mario Luppi, Enrico Crea, Paola Fazi, Francesco Passamonti, Paolo Corradini
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study. British journal of haematology 199 (1) (2022)
Paola Alberti, Alessandro Salvalaggio, Haralabos P Kalofonos, Jordi Bruna, Andrea Visentin, Guido Cavaletti, Chiara Briani
Neurological Complications of Conventional and Novel Anticancer Treatments. Cancers 14 (24) (2022)
Andrea Visentin, Stefano Pravato, Francesca Castellani, Marta Campagnolo, Francesco Angotzi, Chiara Adele Cavarretta, Alessandro Cellini, Valeria Ruocco, Alessandro Salvalaggio, Alessandra Tedeschi, Livio Trentin, Chiara Briani
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance. Cancers 14 (6) (2022)
Shai Levi, Yotam Bronstein, Neta Goldschmidt, Fortunato Morabito, Tomer Ziv-Baran, Giovanni Del Poeta, Osnat Bairey, Maria Ilaria Del Principe, Riva Fineman, Francesca Romana Mauro, Odit Gutwein, Gianluigi Reda, Rosa Ruchlemer, Paolo Sportoletti, Luca Laurenti, Lev Shvidel, Marta Coscia, Tamar Tadmor, Marzia Varettoni, Ariel Aviv, Roberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. American journal of hematology (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio Trentin, Daniela Pietrasanta, Idanna Innocenti, Luca Laurenti
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood advances 6 (13) (2022)
Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, Andrea Visentin, Francesca Romana Mauro, Idanna Innocenti, Massimo Gentile, Diana Giannarelli, Alessandro Noto, Ramona Cassin, Antonino Neri, Luca Laurenti, Alessandra Tedeschi
Ibrutinib in patients over 80 with chronic lymphocytic leukemia: a multicenter Italian cohort. Blood advances (2022)
Chiara Briani, Andrea Visentin, Francesca Castellani, Mario Cacciavillani, Livio Trentin
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies. Neurology(R) neuroimmunology & neuroinflammation 9 (4) (2022)
Monia Marchetti, Candida Vitale, Gian Matteo Rigolin, Alessandra Vasile, Andrea Visentin, Lydia Scarfò, Marta Coscia, Antonio Cuneo
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence. Journal of clinical medicine 11 (8) (2022)
Stefano Molica, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Riccardo Moia, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Marina Deodato, Claudia Ielo, Alessandro Noto, Valerio Guarente, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foa', Livio Trentin, Francesca Romana Mauro
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. American journal of hematology 97 (5) (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Chiara Briani, Andrea Visentin, Francesca Castellani, Mario Cacciavillani, Livio Trentin
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies. Neurology(R) neuroimmunology & neuroinflammation 9 (4) (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco A Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current oncology (Toronto, Ont.) 30 (1) (2022)
Laura Evangelista, Filippo Crimi', Andrea Visentin, Giacomo Voltan, Livio Trentin, Carmelo Lacognata, Diego Cecchin, Filippo Ceccato
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases. Current oncology (Toronto, Ont.) 29 (10) (2022)
Chiara Briani, Sergio Ferrari, Marta Campagnolo, Matteo Tagliapietra, Francesca Castellani, Alessandro Salvalaggio, Sara Mariotto, Andrea Visentin, Tiziana Cavallaro
Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies. Brain sciences 11 (2) (2021)
Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. Blood 137 (25) (2021)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Daniele Caracciolo, Ramona Cassin, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American journal of hematology 96 (5) (2021)
Fortunato Morabito, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Anna Grazia Recchia, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Enrica Antonia Martino, Ernesto Vigna, Giovanni Tripepi, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Ozren Jaksic, Jacopo Olivieri, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. American journal of hematology 96 (8) (2021)
Francesca Romana Mauro, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Claudia Ielo, Alessandro Noto, Valerio Guarente, Stefano Molica, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foà, Maurizio Martelli, Corrado Girmenia, Giuseppe Gentile, Livio Trentin
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Cancers 13 (13) (2021)
Federica Frezzato, Andrea Visentin, Filippo Severin, Serena Pizzo, Edoardo Ruggeri, Nayla Mouawad, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Alessia Tonini, Samuela Carraro, Stefano Pravato, Silvia Imbergamo, Sabrina Manni, Francesco A Piazza, Anna Maria Brunati, Monica Facco, Livio Trentin
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers 13 (21) (2021)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Ernesto Vigna, Enrica Antonia Martino, Ramona Cassin, Graziella D Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Paola Menichini, Paola Menichini, Jacopo Olivieri, Giovanna Cutrona, Davide Rossi, Antonio Cuneo, Francesco Di Raimondo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. American journal of hematology 96 (8) (2021)
Fulvio Massaro, Vincenzo Pavone, Piero Maria Stefani, Barbara Botto, Alessandro Pulsoni, Caterina Patti, Maria Cantonetti, Andrea Visentin, Potito Rosario Scalzulli, Andrea Rossi, Sara Galimberti, Michele Cimminiello, Guido Gini, Maurizio Musso, Marco Sorio, Annalisa Arcari, Vittorio Ruggero Zilioli, Mario Luppi, Donato Mannina, Alberto Fabbri, Giuseppe Pietrantuono, Ombretta Annibali, Agostino Tafuri, Eleonora Prete, Antonino Mulè, Elisa Barbolini, Luigi Marcheselli, Stefano Luminari, Francesco Merli
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience. Hematological oncology (2021)
Andrea Visentin, Francesca Romana Mauro, Francesca Cibien, Candida Vitale, Gianluigi Reda, Alberto Fresa, Stefania Ciolli, Daniela Pietrasanta, Monia Marchetti, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Lydia Scarfò, Paolo Sportoletti, Stefano Pravato, Francesco Piazza, Marta Coscia, Luca Laurenti, Stefano Molica, Robin Foà, Antonio Cuneo, Livio Trentin
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. American journal of hematology 97 (3) (2021)
Francesco Cinetto, Raffaella Neri, Fabrizio Vianello, Andrea Visentin, Gregorio Barilà, Sabrina Gianese, Alison Lanciarotta, Cinzia Milito, Marcello Rattazzi, Francesco Piazza, Livio Trentin, Renato Zambello, Carlo Agostini, Riccardo Scarpa
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies. PloS one 16 (3) (2021)
Chiara Briani, Andrea Visentin, Federica Cerri, Angelo Quattrini
From pathogenesis to personalized treatments of neuropathies in hematological malignancies. Journal of the peripheral nervous system : JPNS 25 (3) (2020)
Gessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, Anna Candoni, Chiara Cattaneo, Luca Laurenti, Rosa Fanci, Francesca Farina, Federica Lessi, Andrea Visentin, Francesco Marchesi, Lucia Prezioso, Angelica Spolzino, Maria Chiara Tisi, Fabio Trastulli, Marika Picardi, Luisa Verga, Michelina Dargenio, Alessandro Busca, Livio Pagano, null null
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study. British journal of haematology 193 (2) (2020)
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, Stefano Pravato, Leila Romano Gargarella, Federica Frezzato, Greta Scapinello, Roberta Bertorelle, Elisa Piva, Monica Facco, Gianpietro Semenzato, Francesco A Piazza, Livio Trentin
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature. Hematological oncology 38 (5) (2020)
Andrea Visentin, Federica Frezzato, Filippo Severin, Silvia Imbergamo, Stefano Pravato, Leila Romano Gargarella, Sabrina Manni, Serena Pizzo, Edoardo Ruggeri, Monica Facco, Anna Maria Brunati, Gianpietro Semenzato, Francesco A Piazza, Livio Trentin
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia. OncoTargets and therapy 13 (2020)
Ramona Cassin, Andrea Visentin, Diana Giannarelli, Alessandro Noto, Francesca Romana Mauro, Luca Baldini, Livio Trentin, Gianluigi Reda
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients. Hematological oncology 39 (1) (2020)
Andrea Visentin, Marina Deodato, Francesca R Mauro, Francesco Autore, Gianluigi Reda, Candida Vitale, Stefano Molica, Gian Matteo Rigolin, Francesco Piazza, Laura Cesini, Alessandra Tedeschi, Luca Laurenti, Ramona Cassin, Marta Coscia, Antonio Cuneo, Robin Foà, Gianpietro Semenzato, Livio Trentin
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia. Hematological oncology 37 (4) (2019)
Mario Angelo Pagano, Elena Tibaldi, Pierfrancesco Molino, Federica Frezzato, Valentina Trimarco, Monica Facco, Giuseppe Zagotto, Giovanni Ribaudo, Luigi Leanza, Roberta Peruzzo, Ildikò Szabò, Andrea Visentin, Martina Frasson, Gianpietro Semenzato, Livio Trentin, Anna Maria Brunati
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL. Leukemia 33 (5) (2018)
Andrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, Stefano Pravato, Federica Frezzato, Laura Bonaldi, Marco Pizzi, Stefania Vio, Michele Gregianin, Marta Burei, Monica Facco, Gianpietro Semenzato, Francesco Piazza, Livio Trentin
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome. British journal of haematology 185 (1) (2018)
Sara Canovas Nunes, Martina Manzoni, Marco Pizzi, Elisa Mandato, Marilena Carrino, Laura Quotti Tubi, Renato Zambello, Fausto Adami, Andrea Visentin, Gregorio Barilà, Livio Trentin, Sabrina Manni, Antonino Neri, Gianpietro Semenzato, Francesco Piazza
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma. Blood cancer journal 8 (2) (2018)
Andrea Visentin, Elena Campello, Edoardo Scomazzon, Luca Spiezia, Silvia Imbergamo, Stefano Pravato, Francesco Piazza, Gianpietro Semenzato, Paolo Simioni, Livio Trentin
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases. Hematological oncology 36 (5) (2018)
Andrea Visentin, Chiara Briani, Silvia Imbergamo, Federica Frezzato, Annalisa Angelini, Marny Fedrigo, Mario Cacciavillani, Sara Altinier, Francesco Piazza, Gianpietro Semenzato, Fausto Adami, Livio Trentin
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia. Hematological oncology 36 (1) (2017)
Andrea Visentin, Carmela Gurrieri, Silvia Imbergamo, Federica Lessi, Speranza Antonia Di Maggio, Federica Frezzato, Fausto Adami, Renato Zambello, Francesco Piazza, Gianpietro Semenzato, Livio Trentin
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia. Hematological oncology 35 (4) (2016)

Andrea Visentin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Visentin